Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

STRIDES

Eli Lilly · Phase 2 · Terminated · Enrollment 204

NCT06515418

ArmPopulationDoseWeeksEstimandWeight change
A: Tirzepatide MonotherapyObesity or overweightn/r48n/rn/r
B: Azelaprag once daily plus TirzepatideObesity or overweightn/r48n/rn/r
C: Azelaprag twice daily plus TirzepatideObesity or overweightn/r48n/rn/r
D: Azelaprag MonotherapyObesity or overweightn/r48n/rn/r